Statins Viable Cure for Cancers

Late Stage Cancer Cure on the Horizon

By travels, published Apr 28, 2008
Published Content: 317  Total Views: 509,357  Favorited By: 2 CPs
Rating: 3.0 of 5
Statins are class of hypolipidemic drugs inhibit an enzyme HMG - CoA reductase, which superbly lower cholesterol levels, preventing the risk of cardiovascular disease (Reabsorbing cholesterol accumulation referred to as plaque on artery walls, preventing blood vessels from blockage 2). Precisely Statins lower bad cholesterol, otherwise known as LDL cholesterol by 30 - 50%, and raise good cholesterol (HDL-cholesterol). 1 Among the most widely prescribed Statins in the western world include: Simvastatin (Zocor), atorvastalin (Lipitor), pravastatin (Pravachol), lovastatin (Mevacor), rosuvastatin (Crestor) and others. 2 Statin medication maybe prescribed by a physician when total cholesterol level exceeds 240 milligrams or bad cholesterol LDL exceeds more than 130 milligrams. However, other factors must be considered before prescribing a statin medication including general health of the patient, excess weight, smoking, age, and more. High cholesterol level risks development of a heart attack or stroke. Prescribed statin dosage various from 5 - 80 milligrams, depending on initial LDL cholesterol evaluation level. Most of the time, no side effects are apparent, however some people may experience liver damage and muscle problems, which may go away as the body adjusts to the medication. 2

Scientists studying statins have started to understand not only prevented cardiovascular disease but could significantly cure cancers by working against cellular functions that may help control tumor initiation, growth and metastais (spread). When the enzyme HMG - CoA reductase is blocked, prevents a pivotal role it plays, arresting cancer process. 3

Takeaways
  • Enzyme HMG - CoA reductase is blocked arresting cancer process.
  • Statins reduce by more than 50% risk developing pancreatic & esophageal cancer.
  • Hypothesis statins may reduce lung and colorectal cancers.
Did You Know?
Robert Wood Johnson Medical School of the University of Medicine and Dentistry of New Jersey in Brunswick plan to conduct human clinical trials, combining Liptor and Celbrex treat cancer patients.
Comments
Type in Your Comments Below
Your name:

Submit your own content on this or any topic. Get started »
Most Commented On